Alain Stépanian

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

Éric Mariotte, Élie Azoulay, Lionel Galicier et al. · The Lancet Haematology · 2016 · 312 citations

Medicine, Hematology, Pathology +7

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura

Marie Moatti-Cohen, Céline Garrec, Martine Wolf et al. · Blood · 2012 · 260 citations · Full text

Medicine, Hematology, Obstetrics +9

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

Nick van Es, Marcello Di Nisio, Gabriela Cesarman et al. · Haematologica · 2017 · 233 citations · Full text

Medicine, Hematology, Oncology +17

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15